Sunday Research Poster Presentations - ISPOR · Sunday Research Poster Presentations ... PHP1 A1...
Transcript of Sunday Research Poster Presentations - ISPOR · Sunday Research Poster Presentations ... PHP1 A1...
Sunday Research Poster Presentations
Poster Display Hours – 12:30 PM - 7:30 PM Poster Author Discussion Hour – 6:30 PM - 7:30 PM
POSTER PRESENTATIONS: PHP: HEALTH CARE USE & POLICY STUDIES ROWS A-N PGI: GASTROINTESTINAL DISORDERS ROWS N-O PMH: MENTAL HEALTH ROWS O-R PSS: SENSORY SYSTEMS DISORDERS ROWS R-S PUK URINARY/KIDNEY DISORDERS ROWS S-T
Research Poster Presentations Acceptance Code PDF Page # Topic – Subtopic PHP1-PHP3 21 Health Care Use & Policy Studies - Consumer Role in Health Care PHP4-PHP26 22 Health Care Use & Policy Studies - Drug/Device/Diagnostic Use & Policy PHP27-PHP29 31 Health Care Use & Policy Studies - Equity and Access PHP30-PHP32 33 Health Care Use & Policy Studies - Formulary Development PHP33-PHP73 34 Health Care Use & Policy Studies - Health Care Costs & Management PHP74-PHP105 51 Health Care Use & Policy Studies - Health Care Research & Education PHP106-PHP115 63 Health Care Use & Policy Studies - Health Technology Assessment Programs PHP116-PHP117 68 Health Care Use & Policy Studies - Population Health PHP118-PHP121 69 Health Care Use & Policy Studies - Prescribing Behavior & Treatment Guidelines PHP122-PHP123 70 Health Care Use & Policy Studies - Quality of Care PHP124-PHP125 71 Health Care Use & Policy Studies - Regulation of Health Care Sector PHP126-PHP129 72 Health Care Use & Policy Studies - Risk Sharing/Performance-Based Agreements PHP130-PHP136 74 Health Care Use & Policy Studies - Conceptual Papers
PGI1-PGI2 76 Gastrointestinal Disorders - Clinical Outcomes Studies PGI3-PGI6 77 Gastrointestinal Disorders - Cost Studies PGI7-PGI9 79 Gastrointestinal Disorders - Patient-Reported Outcomes & Patient Preference Studies PGI10-PGI15 80 Gastrointestinal Disorders - Health Care Use & Policy Studies
PMH1-PMH7 82 Mental Health - Clinical Outcomes Studies PMH8-PMH16 85 Mental Health - Cost Studies PMH17-PMH22 89 Mental Health -Reported Outcomes & Patient Preference Studies PMH23-PMH26 91 Mental Health - Health Care Use & Policy Studies
PSS1-PSS 93 Sensory Systems Disorders - Clinical Outcomes Studies PSS2-PSS4 93 Sensory Systems Disorders - Cost Studies PSS5-PSS9 95 Sensory Systems Disorders - Patient-Reported Outcomes & Patient Preference Studies PSS10-PSS11 97 Sensory Systems Disorders - Health Care Use & Policy Studies
PUK1-PUK3 98 Urinary/Kidney Disorders - Clinical Outcomes Studies PUK4-PUK8 99 Urinary/Kidney Disorders - Cost Studies PUK9-PUK13 101 Urinary/Kidney Disorders - Patient-Reported Outcomes & Patient Preference Studies PUK14-PUK16 103 Urinary/Kidney Disorders - Health Care Use & Policy Studies
HEALTH C RESEARCH POSTER PRESENTATIONS - SESSION I HEALTH CARE USE & POLICY STUDIES
HEALTH CARE USE & POLICY STUDIES - Consumer Role in Health Care
PHP1 A1 SELF-MEDICATION WITH ANTIBIOTICS IN SANA'A CITY
Albawani S, Gnanasan S, Abd. Aziz N, Hassan Y,Universiti Teknologi MARA, Puncak Alam, Malaysia
PHP2 A2 SCHOOLS' PERSPECTIVE ON PROMOTING RATIONAL USE OF ANTIBIOTICS IN NEW DELHI, INDIA – A QUALITATIVE STUDY
Kotwani A, Holloway K,WHO-SEARO, New Delhi, India
PHP3 A3 COMPARISION OF PERCEPTION TOWRDS GENERIC MEDICINES BETWEEN FINAL YEAR PHARMACY AND MEDICAL STUDENTS IN SOUTHEAST YEMEN
AL-Tamimi SK1, Hassali MA
1, Shafie AA
1, Alrasheedy AA
2,1Universiti Sains Malaysia, Penang, Malaysia,
2Qassim University,
Qassim, Saudi Arabia
HEALTH CARE USE & POLICY STUDIES - Drug/Device/Diagnostic Use & Policy
PHP4 A4 APPLICATION OF MULTI-CRITERIA DECISION ANALYSIS (MCDA) SCORING AS AN HTA METHODOLOGY FOR OFF-PATENT PHARMACEUTICALS (OPP) IN EMERGING MARKETS
Brixner D1, Maniadakis N
2, Kaló Z
3, Hu S
4, Johnston A
5, Shen J
6, Wijaya KE
7,1Personalized Health Care, University of Utah
Health Sciences Center, Salt Lake City, UT, USA, 2National School Of Public Health, Athens, Greece,
3Eötvös Loránd University,
Budapest, Hungary, 4Fudan University, Shanghai, China,
5Queen Mary University of London, London, UK,
6Abbott Laboratories,
Abbott Park, IL, USA, 7Abbott Laboratories, Allschwil, Switzerland
PHP5 A5 ARE US PRIVATE PAYERS' MEDICAL POLICIES INFLUENCED BY COCHRANE EVIDENCE?
Singh A1, Hussain S
2, Najmi AK
2,1Independent Researcher, New Delhi, India,
2Faculty of Pharmacy, Jamia Hamdard, Hamdard
University, New Delhi, India
PHP6 A6 ‘SEVERE ILLNESS INSURANCE' IN CHINA: IMPACT OF THE NEW COVERAGE ON ACCESS TO HEALTH CARE AND INNOVATIVE DRUGS
Sherwin G, Akpinar P, Yap B, Li X,ICON plc, LONDON, UK
PHP7 A7 FREE ESSENTIAL MEDICINES THROUGH PUBLIC HEALTH FACILITIES IN NEPAL: A QUALITATIVE STUDY
Acharya M1, Dahal A
2,1University of Arkansas for Medical Sciences, Little Rock, AR, USA,
2The University of Toledo, Toledo,
OH, USA
PHP9 A8 SUGGESTION ON CRITICAL ILLNESS INSURANCE IN CHINA
Zhu L, Xu H, Cui X,Sanofi China, Shanghai, China
PHP10 A9 ONLINE PHARMACY REGULATION IN INDIA: A CROSS SECTIONAL SURVEY ON PERCEPTIONS OF HEALTH CARE STUDENTS/PROFESSIONALS
Peringadi Vayalil M, Rajesh V, Rajan MS, Girish T,Manipal University, Manipal, Udupi Dist., India
PHP11 A10 DEVELOPMENT OF HOSPITAL FORMULARY IN JAPAN - CURRENT TRENDS AND ISSUES
Hamashima Y1, Hamashima C
2,1University of Tokyo Hospital, Tokyo, Japan,
2National Cancer Center, Tokyo, Japan
PHP12 B1 HOW DOES PRICING AND ACCESS OF INNOVATIVE ONCOLOGY AGENTS IN CHINA COMPARE WITH OTHER ASIAN MARKETS?
Sherwin G, Akpinar P, Yap B, Lu V, Im Y,ICON plc, LONDON, UK
PHP13 B2 WHAT IMPACT IS THE EVOLVING HEALTH CARE LANDSCAPE HAVING ON ACCESS TO INNOVATIVE MEDICINES IN CHINA?
Sherwin G, Akpinar P, Yap B,ICON plc, LONDON, UK
PHP14 B3 ASSESSMENT OF BIOSIMILAR LANDSCAPE IN KOREA, MALAYSIA, SINGAPORE AND TAIWAN
Chen S1, Conti CC
2, Cheong J
1,1GfK Singapore, Singapore, Singapore,
2GfK, London, UK
PHP15 B4 THE PRICING AND REIMBURSEMENT OF SPECIALTY DRUGS IN KEY ASIAN MARKETS
Subramanian D, Dummett H,EMAX Solutions, Singapore, Singapore
PHP16 B5 BUILDING INTENTIONS WITH THE THEORY OF PLANNED BEHAVIOUR: THE MEDIATING ROLE OF KNOWLEDGE AND EXPECTATIONS IN SUCCESSFUL NEW PHARMACY PUBLIC HEALTH SERVICES IMPLEMENTATION
Hoay TL1, Hassali MA
1, Gan V
2, Saleem F
1,1Universiti Sains Malaysia, Penang, Malaysia,
2Universiti Putra Malaysia, Serdang,
Malaysia
PHP17 B6 GENERAL PUBLIC KNOWLEDGE AND AWARENESS ABOUT MEDICINES USE IN PENANG, MALAYSIA
Dawood OT, Hassali MA, Saleem F,Universiti Sains Malaysia, Penang, Malaysia
PHP18 B7 QUINOLONES UTILIZATION IN TWO TERTIARY HOSPITALS IN NIGERIA; A PHARMACOEPIDEMIOLOGICAL SURVEY
Ogbonna B1, Eze L
1, Ogbonna C
2, Ejim C
2,1NNAMDI AZIKIWE UNIVERSITY, ANAMBRA STATE, Nigeria,
2ENUGU STATE
UNIVERSITY TEACHING HOSPITAL, ENUGU, NIGERIA, ENUGU, Nigeria
PHP19 B8 ATTITUDE TOWARDS THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINES (CAM) AMONG PHARMACY AND MEDICAL STUDENTS. A COMPARATIVE STUDY
Farooqui M1, Othman CN
1, Sadeeqa S
2, Farooqui MA
3, ul Haq N
4,1Universiti Teknologi MARA (UiTM), Kepala Batas,
Malaysia, 2Institute of Pharmacy, Lahore, Pakistan,
3Kolej Universiti Insaniah, Kuala Ketil, Kedah,, Malaysia,
4University of
Balochistan, Quetta, Pakistan
PHP20 B9 DRUG UTILIZATION IN AN OUTPATIENT PRIVATE PAEDIATRIC SETTING: AN OBSERVATIONAL STUDY
Deshwal S1, Tiwari P
1, Kumar N
2,1National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali),
Punjab, India, 2Chaitanya Hospital, Chandigarh, India
PHP21 B10 DRUG UTILIZATION STUDY OF ANTIBIOTICS IN A SECONDARY CARE REFERRAL HOSPITAL
Rathikanti V,chalapathi institute of pharmaceutical sciences, Vijayawada, India
PHP22 C1 PERLIMINARY STUDY OF MEDICATION REGIMEN COMPLEXITY AMONG TAIWANESE ELDERLY WHO HAVE USED ANXIETY OR HYPNOTICS PRESCRIPTIONS
Chen J1, Simonavice CA
2, Chen Y
2, Lin H
1,1China Medical University, Taichung, Taiwan,
2China Medical University Hospital,
Taichung, Taiwan
PHP23 C2 WHAT DO WE PAY FOR COMPOUNDED DRUGS?
Lin T1, Tran DM
2, Shoair OA
2, Huang W
1, Cao V
1, Wilson L
2,1UCSF, San Francisco, CA, USA,
2University of California, San
Francisco, San Francisco, CA, USA
PHP24 C3 A NATIONWIDE SURVEY ON INFECTION CONTROL ACTIVITIES WITHIN HOSPITALS ALLOWED TO IMPLEMENT PREFERENTIAL INFECTION PREVENTION COUNTERMEASURE FEE IN JAPAN
Hirose M1, Nishimura N
2, Naora K
2, Imanaka Y
3,1Shimane University, Izumo, Japan,
2Shimane University Hospital, Izumo,
Japan, 3Kyoto University, Kyoto, Japan
PHP25 C4 ASSOCIATION OF SOCIOECONOMIC CONDITIONS AND DRUG OFFENCES AND REINCARCERATION
Huang C, Yang M,National Taiwan University, Taipei, Taiwan
PHP26 C5 ASSESSMENT OF PRESCRIBING INDICATORS IN PUBLIC AND PRIVATE PRIMARY HEALTH CARE FACILITIES IN INDONESIA
Yuniar Y, Susyanty AL, Sari ID,National Institute of Health Research and Development, Central Jakarta, Indonesia
HEALTH CARE USE & POLICY STUDIES - Equity and Access
PHP27 C6 A REVIEW OF PHARMECEUTICAL POLICIES IN RESPONSE TO ECONOMIC CRISIS AND SANCTIONS
Kheirandish M,Tehran university of medical sciences, tehran, Iran (Islamic Republic of)
PHP28 C7 EQUITY OF GOVERNMENT SUBSIDY IN HEALTH CARE: A CASE STUDY IN CHINA
Si L1, Chen M
2, Palmer AJ
3,1University of Tasmaina, Hobart, Australia,
2Nanjing Medical Univeristy, Nanjing, China,
3Menzies
Institute for Medical Research, Hobart, Australia
PHP29 C8 DEVELOPING HTA GUIDELINES FOR RARE DISEASE THERAPIES - AN INDUSTRY PERSPECTIVE
Taylor CB1, Weston AR
1, Milliner C
2, Schulz S
2, Clark F
3, Goodall A
3, Brown A
4, Chim L
5, Kwasha D
5, Quinn E
6, McDonnell T
7,
Evans K8,1Asia Pacific, Sydney, Australia,
2Shire, North Ryde, Australia,
3Sanofi Genzyme, Macquarie Park, Australia,
4Sanofi
Australia, Macquarie Park, Australia, 5Alexion Pharmaceuticals Australasia, Frenchs Forest, Australia,
6Vertex Pharmaceuticals
(Australia), St Leonards, Australia, 7A. Menarini Australia, Chatswood, Australia,
8BioMarin Pharmaceutical Australia, Crows
Nest, Australia
HEALTH CARE USE & POLICY STUDIES - Formulary Development
PHP31 C9 WHAT'S NEW IN THE GUIDELINES FOR SUBMISSION OF DOSSIER FOR LISTING INTO THE MINISTRY OF HEALTH MEDICINES FORMULARY (MOHMF) ?
Low EV, Ramli A, Lajis R, Aryani Md Yusof F,Ministry of Health Malaysia, Petaling Jaya, Malaysia
PHP32 C10 TEMPERATURE, REAL TIME, ON SITE, POTENCY MONITORING STUDIES OF DIFFERENT BRANDS OF CEPHALEXIN TABLETS STORED IN HOSPITAL AND COMMUNITY PHARMACIES IN DIFFERENT PART OF KERALA
Kiron sS,academy of pharmaceutical sciences, kannur, India
HEALTH CARE USE & POLICY STUDIES - Health Care Costs & Management
PHP33 D1 CONSTRUCTION OF SYSTEM DYNAMICS MODEL FOR MEDICAL CARE SYSTEM OF JAPAN
Inoue S1, Xu H
2, Maswana J
2, Kobayashi M
1,1CRECON Medical Assessment Inc., Tokyo, Japan,
2University of Tsukuba, Tokyo,
Japan
PHP34 D2 THE STUDY OF DRUG PRICE COMPRISON BETWEEN CHINA AND 14 OTHER COUNTRIES
Liu B1, Su W
2, Mo Y
1,1Department of Health Economics, School of Public Health, Fudan University, Shanghai, China,
2IHS Life
Sciences, Washington, DC, USA
PHP35 D3 THE FIRST INDONESIAN HEALTH-RELATED QUALITY OF LIFE VALUATION STUDY: AN EQ-5D-5L VALUE SET
Purba FD1, Hunfeld J
1, Iskandarsyah A
2, Fitriana TS
3, Sadarjoen SS
2, Passchier J
4, van Busschbach J
1,1Erasmus MC,
Rotterdam, The Netherlands, 2Padjadjaran University, Jatinangor, Indonesia,
3YARSI University, Jakarta, Indonesia,
4VU
University, Amsterdam, The Netherlands
PHP36 D4 COST VARIATIONS OF INPATIENT, DAYCARE AND OUTPATIENT HYSTEROSCOPY IN A TERTIARY-CARE HOSPITAL IN MALAYSIA
Shabaruddin FH, Chai BS, Woo YL, Dahlui M,University of Malaya, Kuala Lumpur, Malaysia
PHP37 D5 SPIRALLING HEALTHCARE EXPENDITURE IN MALAYSIA: IS IT SUSTAINABLE?
Perumal AK,B. Braun, KL, Malaysia
PHP38 D6 UNIVERSAL HEALTH COVERAGE IN COUNTRIES ACROSS EAST AND SOUTHEAST ASIA – ASSOCIATIONS BETWEEN HEALTH EXPENDITURE AND SERVICE PROVISION
Evans JS, Wickstead RM, Hanman K, Steeves S,Costello Medical Consulting Ltd, Cambridge, UK
PHP39 D7 THE IMPACTS OF CASE PAYMENT IN RURAL HAINAN OF CHINA
He L, Yang L,Peking University, Beijing, China
PHP40 D8 COSTS AND BENEFITS OF HOME FOOD INDUSTRY ISSUANCE PROGRAM IN INDONESIA
Sucahya pK1, Sari K
2,1Center for Health Research Universitas Indonesia, Depok, Indonesia,
2Center for Health Economics and
Policy Studies Universitas Indonesia, Depok, Indonesia
PHP41 D9 EXPERIENCE SEEKING APPROPRIATE STANDARDS OF COST-EFFECTIVENESS RATIO: UPDATES AND CHALLENGES IN JAPANESE SETTING
Kamae I, Sugimoto T,The University of Tokyo, Graduate School of Public Policy, Tokyo, Japan
PHP42 D10 ICT DIFFUSION AND PHARMACEUTICALS (ISSUES FOR DECISION TOOLS)
Huttin CC,Endepusresearchinc and Univ Aix Marseille, Cambridge, MA, USA
PHP43 E1 APPLICATION LIMITATIONS OF COST MINIMIZATION ANALYSIS IN CHINA
Zhu L, Cui X, Xu H,Sanofi China, Shanghai, China
PHP44 E2 RISK OF DISCONTINUATION OF ADVANCED THERAPY MEDICINAL PRODUCTS CLINICAL TRIALS
Hanna E1, Rémuzat C
2, Toumi M
1,1Faculté de Médecine, Laboratoire de Santé Publique, Aix-Marseille Université, Marseille,
France, 2Creativ-Ceutical, Paris, France
PHP45 E3 OUTCOMES FROM HOMEOPATHIC PRESCRIBING IN SECONDARY CARE HOMEOPATHIC HOSPITAL: A PROSPECTIVE STUDY
Dobariya N1, Tiwari P
1, Dhiman K
2, Sareen P
2, Anand T
2, Sharda S
2, Manku Tk
2, Kaur R
2,1National Institute of Pharmaceutical
Education and Research (NIPER), S.A.S. Nagar (Mohali), Punjab, India, 2Homeopathic Medical College and Hospital,
Chandigarh, India
PHP46 E4 HIGH-RISK MEDICATIONS AND UNPLANNED HOSPITALIZATIONS: A CASE–TIME–CONTROL STUDY
Lin C1, Wen Y
2, Chen L
3, Hsiao F
1,1National Taiwan University, Taipei, Taiwan,
2Chang Gung University, Taoyuan,
Taiwan, 3Taipei Veterans General Hospital, Taipei, Taiwan
PHP47 E5 IMPLEMENTATION OF ADVERSE EVENT TRIGGER TOOL SYSTEM FOR ASSESSING PATIENT SAFETY
Vilakkathala R1, Mallayasamy S
1, K V
1, Rodrigues GS
2, BH AR
2,1Manipal University, Manipal, India,
2Kasturba Medical College,
Manipal, India
PHP48 E6 WHAT ARE THE KEY CONCERNS OF HEALTH CARE PROVIDERS IN CHINA? QUALITATIVE INVESTIGATION OF A DOUBLE-BLIND TELEPHONE SURVEY
Sun Y1, Liu GG
1, Wang T
2, You X
1, Zhao H
1,1Peking University, Beijing, China,
2Shenyang Pharmaceutical University,
Shenyang, China
PHP49 E7 FACTORS ASSOCIATED WITH 90-DAY OR 180-DAY LONG-TERM USE OF ANXIETY-HYPNOTIC PRESCRIPTIONS AND ECONOMIC AND SAFETY OUTCOMES: A RETROSPECTIVE COHORT STUDY
Lin H1, Tsai H
2, Liu F
3, Liao C
4, Li C
5, Lin C
4, Chou C
4, Chang C
4, Simonavice CA
4, Li T
1,1China Medical University, Taichung,
Taiwan, 2Providence University, Taichung City, Taiwan,
3Hsuan Chuang University, Hsinchu City, Taiwan,
4China Medical
University Hospital, Taichung, Taiwan, 5China Medical University Hospital, Taiwan, Taichung, Taiwan
PHP50 E8 EFFECTIVENESS OF TRIGGER TOOLS TO DETECT ADVERSE DRUG EVENTS FROM DISCHARGE SUMMARIES: A RETROSPECTIVE STUDY
Anburaj E1, Vilakkathala R
2, Mallayasamy S
2, Stanley W
2,1Manipal College of Pharmaceutical Sciences, Manipal,
India, 2Manipal University, Manipal, India
PHP51 E9 EVALUATION OF ATTITUDE AND PERCEPTION OF RETAIL PHARMACISTS TOWARDS PATIENT SAFETY
Sivanandy P, Marikannan M, Tan Tyng W, Tan Wee L, Lim Chong Y,International Medical University, Kuala Lumpur, Malaysia
PHP52 E10 IN-LICENSING AS A BUSINESS STRATEGY FOR PHARMACEUTICAL COMPANIES: A FRAMEWORK FOR THE NIGERIAN INDUSTRY
Keshi CB,UGSM-, Zug, Switzerland
PHP53 F1 A STUDY ON IDENTIFICATION, MONITORING AND MANAGEMENT OF ADVERSE DRUG REACTIONS IN A TERTIARY CARE HOSPITAL
Vudugu R, Eluka vL, Konuru V, Sagar SV, Kachapuram rC,St.Peter's Institute of Pharmaceutical Sciences, Hanamkonda, India
PHP54 F2 CHRONIC PATIENTS ATTITUDES, BELIEFS, AND EXPERIENCES REGARDING POLYPHARMACY AND WILLINGNESS TO DEPRESCRIBE IN QUETTA
ul Haq N, Mohaib M, Nasim A, Razaque G, Riaz S,University of Balochistan, Quetta, Pakistan
PHP55 F3 PERSONALIZED ADAPTIVE REWARDS VERSUS INCENTIVES TO MOTIVATE SUSTAINABLE HEALTHY BEHAVIORAL CHANGE- A NEO-MASLOWIAN CONCEPTUAL MODEL
Jones CA1, Clark EM
2, Weintraub A
1, Zia A
2,1University of Vermont College of Medicine, Burlington, VT, USA,
2University of
Vermont, Burlington, VT, USA
PHP56 F4 ADVERSE EVENTS ASSOCIATED WITH INTRAVENOUS IMMUNOGLOBULIN IN THAILAND
Sriphiromya P,Ministry of Public Health, Nonthaburi, Thailand
PHP57 F5 A STUDY OF PRESCRIPTION PATTERN OF NON STEROIDAL ANII-INFLAMMATORY DRUGS IN A TERTIARY CARE HOSPITAL
Thiruvengadarajan V1, Thattakudian Sheikuduman MS
2, Chakka G
2, Ramkanth S
1,1Annamacharya College of Pharmacy,
Kadapa, India, 2Annamacharya College of Pharmacy, YSR Kadapa, India
PHP58 F6 THE 2012 UPDATED BEERS CRITERIA IN FALLS RELATED HOSPITALIZATION IN OLDER ADULTS
Chen LL, Ng HT, Siow B, Ong KY, Tay JY, Cheen HH, Lim YL, Mamun K,Singapore General Hospital, Singapore, Singapore
PHP59 F7 EFFECT OF CLINICAL PHARMACIST IN PATIENT SAFETY:A PROSPECTIVE INTERVENTIONAL STUDY
Nafis MA, D Acharya L, Hande HM,Manipal University, Manipal, Udupi, India
PHP60 F8 THE EMERGING ROLES OF PHARMACISTS IN SELECTED TERTIARY HOSPITALS IN PANGASINAN AND LA UNION: FOCUS ON PHARMACEUTICAL CARE AND PHARMACOVIGILANCE
Cabral RP,Pangasinan State University, Urdaneta City, Philippines
PHP61 F9 A PROSPECTIVE ANALYSIS OF ADVERSE DRUG REACTION IN A TERTIARY CARE HOSPITAL
Ramesh S1, Prashant C
1, KrishnaPrabha C
2, Jai Ganesh KP
1, Manikandhan C
1, Sivakumar P
1, Sivasankar M
2,1Nehru College of
Pharmacy, Thrissur District, India, 2National College of Pharmacy, Kozhikode, India
PHP62 F10 DRUG UTILIZATION EVALUATION OF ANTIBIOTICS IN GENERAL MEDICINE DEPARTMENT OF A TERTIARY CARE HOSPITAL
Gowthami B1, Spurthi T
2,1JNTU, Anmantapur, kurnool, India,
2CES college of pharmacy, kurnool, India
PHP63 G1 REFORM OF CHINESE STATE-OWNED ENTERPRISE-AFFILIATED HOSPITAL
Wang T1, Li SC
2, Liu GG
3, Wu Z
1, Sun Y
3,1Shenyang Pharmaceutical University, Shenyang, China,
2The University of
Newcastle, Newcastle, Australia, 3Peking University, Beijing, China
PHP64 G2 ASSESSMENT OF CRITERIA INFLUENCES ON JUDICIOUS SELECTION OF NEW DRUG FOR FUTURE COVERAGE POLICY IN IRAN: AN ANALYSIS WITH STRUCTURAL EQUATION MODELING
Viyanchi A, Niasti F, Rabani T,Hamadan University of medical sciences, Hamadan, Iran
PHP65 G3 CONSOLIDATION OF CHINA'S TWO BASIC MEDICAL INSURANCE PROGRAMS: UNDERSTANDING NEW OPPORTUNITIES FOR ACCESS
MI M1, Suponcic S
2, LIU Y
1,1Navigant Life Sciences, Shanghai, China,
2Navigant Life Sciences, Lawrenceville, NJ, USA
PHP66 G4 IS THE LACK OF INCLUSION ON THE NATIONAL DRUG REIMBURSEMENT LIST THE END OF THE WORLD FOR ACCESS?
MI M1, Suponcic S
2, LIU Y
3,1Navigant Life Science, Shanghai, China,
2Navigant Life Sciences, Lawrenceville, NJ,
USA, 3Navigant Life Sciences, Shanghai, China
PHP67 G5 IMPROVING ACCESS TO NEW ONCOLOGY DRUGS IN THE CHINA MARKET: SHORTENTIME-TO-MARKET AND IMPROVE AFFORDABILITY
LIU Y1, Suponcic S
2, MI M
1,1Navigant Life Sciences, Shanghai, China,
2Navigant Life Sciences, Lawrenceville, NJ, USA
PHP68 G6 PATIENT ACCESS TO HIGH-COST AND HIGH-VALUE SPECIALTY PRODUCTS IN CHINA: REVIEW OF DECISIONS FROM ZHEJIANG, NEIMENGGU, SHANDONG AND JIANGXI
Gambari J, Chowdhury CA, Duttagupta S, Yang M,CBPartners, New York, NY, USA
PHP69 G7 UPCOMING REGULATIONS ON INSURANCE REIMBURSEMENT STANDARD IN CHINA: CHANLLANGES AND OPPORTUNITES FOR MNCS
MI M1, Suponcic S
2, Wang M
3, LIU Y
1,1Navigant Life Sciences, Shanghai, China,
2Navigant Life Sciences, Lawrenceville, NJ,
USA, 3Navigant Life Sciences, London, UK
PHP70 G8 A CASE STUDY ON THE DEVELOPMENT, IMPLEMENTATION AND OUTCOME OF CRITICAL DISEASE INSURANCE IN SHEN ZHEN, CHINA
Jiang J,Jinan University, Guangzhou, China
PHP71 G9 TITLE: ACCESS TO ORPHAN AND ULTRA-ORPHAN DRUGS IN CHINA
Gambari J, Yang M, Chowdhury CA, Duttagupta S,CBPartners, New York, NY, USA
PHP72 G10 HOW MUCH DO THE INSURED CITIZENS KNOW ABOUT THE PERSONAL ACCOUNT OF CHINA'S URBAN EMPLOYEES' BASIC MEDICAL INSURANCE AND WHAT ARE THEIR NEEDS? EVIDENCE FROM GUIZHOU, CHINA
Wu H1, Yi L
2, Ran X
1,1Guizhou Medical University, Guiyang, China,
2Department of human resources and social security of
Guizhou province, Guiyang, China
PHP73 H1 THE ROLE OF ECONOMIC EVIDENCE IN DRUG REIMBURSEMENT: SOUTH KOREA
Bae E1, Lee H
2, Kwon H
3, Yang B
4,1Gyeongsang National University, Jinju, South Korea,
2National Health Insurance Service,
Seoul, South Korea, 3Mokwon University, Daejeon, South Korea,
4Seoul National University, Seoul, South Korea
HEALTH CARE USE & POLICY STUDIES - Health Care Research & Education
PHP74 H2 EVALUATING THE RELATIVE EFFECTIVENESS OF TWO MALNUTRITION RISK ASSESSMENT TOOLS IN SURGICAL POPULATION AT A TERTIARY CARE HOSPITAL IN MALAYSIA
Khan OH1, Khan AH
1, Zakaria AD
2, Hashim MN
2, Sulaiman SA
1,1Universiti Sains Malaysia, Pulau Penang, Malaysia,
2Universiti
Sains Malaysia, Kota Bharu, Malaysia
PHP75 H3 VALUING HEALTH: RESULTS FROM THE HEALTH AUCTION VALUATION EXPERIMENT (HAVE) STUDY
Byrnes J1, Kularatna S
1, Scuffham P
2,1Griffith University, Meadowbrook, Australia,
2Griffith University, Gold Coast, Australia
PHP76 H4 THE STUDY OF THE EFFECT OF PHARMACY MANAGER'S MANAGERIAL SKILLS ON THE PERFORMANCE OF COMMUNITY PHARMACIES OF TEHRAN
Sehat S1, Mirjamali F
2, Rangchian M
3, Mehralian G
4, Salamzadeh J
5,1Islamic Azad University, Tehran, Iran (Islamic Republic
of), 2Shahid Beheshti University of Medical Sciences, Pharmacy School, Tehran, Iran (Islamic Republic of),
3Shahid Beheshti
University of Medical Sciences, School of Pharmacy, Tehran, Iran, 4Shahid Beheshti university of medical Sciences, School of
Pharmacy, Tehran, Iran, 5Shahid Beheshti University of Medical Sciences, School of Pharmacy, Tehran, Iran
PHP78 H5 PREDICTIVE VALIDITY OF NATIONAL NOSOCOMIAL INFECTION SURVEILLANCE (NNIS) AND STUDY ON THE EFFICACY OF NOSOCOMIAL INFECTIONS (SENIC) RISK INDEXES FOR THE INCIDENCE OF SURGICAL SITE INFECTIONS (SSI) IN GENERAL SURGERY AT HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM)
Khan OH1, Zakaria AD
2, Hashim MN
2, Sulaiman SA
1, Khan AH
1,1Universiti Sains Malaysia, Pulau Penang, Malaysia,
2Universiti
Sains Malaysia, Kota Bharu, Malaysia
PHP79 H6 ASSESSMENT OF COMMUNITY PHARMACY SERVICES IN MALAYSIA: PERSPECTIVES FROM COMMUNITY PHARMACISTS, GENERAL PRACTITIONERS, CONSUMERS AND HEALTH POLICY STAKEHOLDERS
Ooi GS1, Ahmad Hassali MA
2, Shafie AA
3, Kong DC
4, Mak V
5, Chua GN
2,1AIMST Univeristy, Bedong, Kedah,
Malaysia, 2Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia,
Penang, Malaysia, 3Universiti Sains Malaysia, Penang, Malaysia,
4Monash University, Victoria, Australia,
5Monash University
Malaysia, Selangor, Malaysia
PHP80 H7 MEDICATION ERRORS AVOIDED BY MEDICATION RECONCILIATION PROCESS AT FEMALE SURGERY WARD IN RAMATHIBODI HOSPITAL, THAILAND
Samarnkongsak T, Samankatiwat P,Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
PHP81 H8 EQ-5D UTILITY VALUE SETS FOR SRI LANKA: A CASE FOR ECONOMIC EVALUATIONS IN SOUTH ASIA
Kularatna S1, Byrnes J
1, Chen G
2, Scuffham P
3,1Griffith University, Meadowbrook, Australia,
2Flinders University, Adelaide,
Australia, 3Griffith University, Gold Coast, Australia
PHP82 H9 KNOWLEDGE, ATTITUDE AND PRACTICE (KAP) REGARDING BLOOD DONATION AMONG HEALTH CARE WORKERS IN MALAYSIA
Farooqui MA1, Yahaya BH
2, Hussien AR
2, Farooqui M
3,1Kolej Universiti Insaniah, Kuala Ketil, Kedah,, Malaysia,
2Universiti
Sains Malaysia, Bertam, Malaysia, 3Universiti Teknologi MARA (Bertam campus), Penang, Malaysia
PHP83 H10 HEALTH RELATED QUALITY OF LIFE FOR DISEASE POPULATION IN CHINA: A SYSTEMATIC REVIEW
Zhou T1, Guan HJ
2, Ma A
1, Liu GG
3,1China Pharmacuetical University, Nanjing, China,
2Peking University China Center for
Health Economic Research, Beijing, China, 3Peking University, Beijing, China
PHP84 I1 THE IMPACT OF DURATION ON EQ‐5D‐5L VALUE SETS DERIVED FROM A DISCRETE CHOICE EXPERIMENT
Norman R1, Mulhern B
2, Viney R
2, Bansback N
3, Pearce A
4,1Curtin University, Perth, Australia,
2University of Technology
Sydney, Sydney, Australia, 3University of British Columbia, Vancouver, BC, Canada,
4National Cancer Registry Ireland, Cork,
Ireland
PHP85 I2 USING BEST-WORST SCALING CHOICE EXPERIMENTS TO ELICIT THE MOST IMPORTANT DOMAINS OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN SINGAPORE
Uy EJ1, Bautista D
2, Xin X
1, Cheung YB
2, Thio S
1, Thumboo J
1,1Singapore General Hospital, Singapore, Singapore,
2Duke-NUS
Medical School, Singapore, Singapore
PHP86 I3 TRENDS IN JAPANESE CLINICAL TRIAL REGISTRATION FROM 2005 TO 2014
Sasaki M1, Fukuda T
2, Shiroiwa T
2, Igarashi A
3, Sato H
1,1National Institute of Public Health, Wako,, Japan,
2National Institute of
Public Health, Wako, Japan, 3University of Tokyo, Graduate School of Pharmaceutical Sciences, Tokyo, Japan
PHP87 I4 A PUBMED BASED SEARCH ON COST EFFECTIVENESS AND HEALTH-RELATED QUALITY OF LIFE STUDIES WITH RESPECT TO COMPLEMENTARY AND ALTERNATIVE MEDICINES
Bhat B1, Sreedhar D
1, Udupa N
2,1Manipal College of Pharmaceutical Sciences, Manipal, India,
2Manipal University, Manipal,
India
PHP88 I5 DEVELOPING ITEM POOLS FOR PHYSICAL FUNCTIONING, SOCIAL RELATIONSHIPS, AND POSITIVE MINDSET TO MEASURE HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE SINGAPORE POPULATION
Uy EJ1, Xiao Y
1, Yeo PT
1, Xin X
1, Pua Y
1, Lee GL
2, Kwan YH
3, Vaingankar JA
4, Subramaniam M
4, Chan MF
5, Kumar N
5,
Bautista D3, Ow MY
3, Lim PA
1, Choo BE
1, Leung YY
1, Chan A
3, Sung SC
3, Kwek TC
1, Cheung YB
3, Thumboo J
1,1Singapore
General Hospital, Singapore, Singapore, 2National University of Singapore, Singapore, Singapore,
3Duke-NUS Medical School,
Singapore, Singapore, 4Institute of Mental Health, Singapore, Singapore,
5Health Promotion Board, Singapore, Singapore
PHP89 I6 COMPARISON BETWEEN THE EQ-5D-5L AND THE EQ-5D-3L FOR GENERAL POPULATION IN CHINA
Zhou T1, Guan HJ
2, Ma A
1, Liu GG
3,1China Pharmacuetical University, Nanjing, China,
2Peking University China Center for
Health Economic Research, Beijing, China, 3Peking University, Beijing, China
PHP90 I7 BUILDING INTENTIONS WITH THE THEORY OF PLANNED BEHAVIOUR: THE MEDIATING ROLE OF KNOWLEDGE AND EXPECTATIONS IN IMPLEMENTING NEW PHARMACEUTICAL SERVICES IN MALAYSIA
Tan CL1, Gan VB
2, Saleem F
3, Hassali MA
3,1Ministry of Health Malaysia, Seremban, Malaysia,
2Universiti Putra Malaysia,
Serdang, Malaysia, 3School of pharmaceutical sciences, Universiti Sains Malaysia, Penang, Malaysia
PHP91 I8 INDICATORS IN EVALUATING FINANCIAL AND ECONOMIC PERFORMANCE OF PHARMACY: A SYSTEMATIC REVIEW
Imani DA, Golestani M, Moghimi M, Janati A,Tabriz University of medical Sciences, Tabriz, Iran
PHP92 I9 ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE OF HOSPITAL ADMITTED PATIENTS IN TERTIARY CARE HOSPITALS QUETTA BY USING SF-12 QUESTIONNAIRE
ul Haq N, Ali T, Nasim A, Razaq G, Riaz S, Yasmin R,University of Balochistan, Quetta, Pakistan
PHP93 I10 EVALUATION OF THE DIFFERENT PHARMACOECONOMIC MODELS ACROSS THE WORLD: A COMPARATIVE STUDY
Kotlo A, Muragundi PM,MCOPS Manipal University, Manipal, India
PHP94 J1 DEVELOPING A COMPREHENSIVE, CULTURALLY SENSITIVE CONCEPTUAL FRAMEWORK OF HEALTH DOMAINS IN SINGAPORE
Uy EJ1, Ow MY
2, Xin X
1, Sung SC
2, Cheung YB
2, Bautista D
2, Thumboo J
1,1Singapore General Hospital, Singapore,
Singapore, 2Duke-NUS Medical School, Singapore, Singapore
PHP95 J2 HOW MUCH ARE CHINESE WILLING TO PAY FOR THE HEALTH IMPROVEMENT?
Sun J, Sun L,Shenyang Pharmaceutical University, Shenyang, China
PHP96 J3 MY OPINIONS MATTER! HOW PERSPECTIVES, KNOWLEDGE AND EXPECTATIONS MATTER IN MODERATING THE SUCCESS OF NEW PHARMACEUTICAL SERVICES IMPLEMENTATION IN MALAYSIA
Tan CL1, Gan VB
2,1Ministry of Health Malaysia, Seremban, Malaysia,
2Universiti Putra Malaysia, Serdang, Malaysia
PHP98 J4 HEALTH STATE VALUATION IN SRI LANKA USING THE EQ-5D-3L; PRECURSOR TO QALY ESTIMATION IN SOUTH ASIA
Kularatna S1, Scuffham P
2,1Griffith University, Meadowbrook, Australia,
2Griffith University, Gold Coast, Australia
PHP99 J5 BILIRUBIN AND NEURODEGENERATIVE DISEASE PREVENTION
Muhsain SN1, Farooqui M
1, Lang M
2, Abu Bakar A
2,1Universiti Teknologi MARA, Kepala Batas, Malaysia,
2University of
Queensland, Coopers Plains, Australia
PHP100 J6 A COMPARATIVE ANALYSIS ON HEALTH SECURITY SYSTEM BETWEEN CHINA AND DEVELOPED COUNTRIES
Wu J1, Liu J
2, Zhu B
2, Mao Y
2,1City University of Hong Kong, Kowloon, Hong Kong,
2Xi'an Jiaotong University, Xi'an, China
PHP101 J7 EVALUATION OF ANTIBACTERIAL AND CYTOTOXIC EFFECTS OF GYMNEMA SYLVESTRE R.BR. SPECIES CULTIVATED IN PAKISTAN AGAINST COMMON RESISTANT PATHOGENS
Tahir M1, Anjum MS
2, Zahid Tanveer M
1, Iqbal MZ
3,1University of Veterinary and Animal Sciences, Lahore, Pakistan;, Lahore,
Pakistan, 2PMAS- Arid Agriculture University, Rawalpindi, Pakistan, Rawalpindi, Pakistan,
3AIMST University, Sungai Petani,
Malaysia
PHP102 J8 WHAT IS GOVERNMENT'S RESPONSIBILITY FOR CHINA'S UNIVERSAL HEALTH SECURITY? AN OUTLOOK FOR A NATIONAL HEALTH SECURITY SYSTEM
Wu J, Liu J, Zhu B, Mao Y,Xi'an Jiaotong University, Xi'an, China
PHP103 J9 APPLICATION OF HEALTHCARE FAILURE MODE & EFFECT ANALYSIS IN IMPROVING PATIENT EDUCATION AT AN OUTPATIENT DEPARTMENT OF A TERTIARY CARE HOSPITAL
Devarakonda S,Armed Forces Medical College, pune, India
PHP104 J10 TRENDS OF INCLUDING PHARMACOECONOMICS COURSE IN THE UNDERGRADUATE PHARMACY CURRICULUM
Thomas D, Sundararaj KG, Shirwaikar A,Gulf Medical University, Ajman, United Arab Emirates
PHP105 K1 THE IMPACT OF SURGICAL PROFESSIONAL EDUCATION: A REVIEW OF CLINICAL AND ECONOMIC OUTCOMES
Bourcet A1, Lim S
2, Metz L
1,1Johnson & Johnson Medical Asia Pacific, Singapore, Singapore,
2Costello Medical Singapore Pte
Ltd, Singapore, Singapore
HEALTH CARE USE & POLICY STUDIES - Health Technology Assessment Programs
PHP106 K2 HEALTH TECHNOLOGY ASSESSMENT SUPPORTS EVIDENCE-BASED DECISION-MAKING IN THE CHANGI GENERAL HOSPITAL MARKETPLACE EXERCISE
Pwee KH, Tong SC, Chow WL,Eastern Health Alliance, Singapore, Singapore
PHP107 K3 ECONOMIC EVALUATION GUIDELINE FOR PHARMACEUTICALS AND MEDICAL DEVICES IN JAPAN
Fukuda T1, Igarashi A
2, Ishida H
3, Ikeda S
4, Saito S
5, Sakamaki H
6, Shimozuma K
7, Shiroiwa T
1, Takura T
8, Tomita N
9, Noto S
10,
Fukuda H11
, Moriwaki K12
, Moriyama Y1, Akazawa M
13,1National Institute of Public Health, Wako, Japan,
2University of Tokyo,
Graduate School of Pharmaceutical Sciences, Tokyo, Japan, 3Yamaguchi University, Ube, Japan,
4International University of
Health and Welfare, Ohtawara, Japan, 5Okayama University, Okayama, Japan,
6Tokyo University of Science, Saitama,
Japan, 7Ritsumeikan University, Kusatsu, Japan,
8Osaka University, Osaka, Japan,
9National Institute of Public Health, Saitama,
Japan, 10
Niigata University of Health and Welfare, Niigata, Japan, 11
Kyushu University, Fukuoka, Japan, 12
Kobe Pharmaceutical University, Kobe, Japan,
13Meiji Pharmaceutical University, Tokyo, Japan
PHP108 K4 A QUANTITATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES FOR ATTRIBUTES DRIVING TRANSPARENCY OF THE ORGANIZATION: COMPARISON OF SIX ASIA-PACIFIC HTA AGENCIES
Mazumder D1, Kapoor A
2, Gwatkin N
3, Medeiros C
4,1Optum, Greater Noida, India,
2Optum Global Solutions, Noida, India,
3Geni
Biopharma, Hampshire, UK, 4Optum Life Sciences, Minneapolis, MN, USA
PHP109 K5 SEGMENTATION OF SEVEN ASIA-PACIFIC HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES INTO DIFFERENT EVOLUTIONARY HTA ARCHETYPES
Mazumder D1, Kapoor A
2, Gwatkin N
3, Medeiros C
4,1Optum, Greater Noida, India,
2Optum Global Solutions, Noida, India,
3Geni
Biopharma, Hampshire, UK, 4Optum Life Sciences, Minneapolis, MN, USA
PHP110 K6 DETERMINING CRITERIA AND WEIGHTS FOR PRIORITISING HEALTH TECHNOLOGIES BASED ON THE PREFERENCES OF THE GENERAL POPULATION: A NEW ZEALAND PILOT STUDY
Sullivan T, Hansen P,University of Otago, Dunedin, New Zealand
PHP111 K7 COMPARISON OF ECONOMIC EVALUATION GUIDELINES BETWEEN JAPAN AND OTHER COUNTRIES
Millier A1, Cheng X
2, Onishi Y
3, Aballéa S
1, Toumi M
1, Doley J
1,1Creativ-Ceutical, Paris, France,
2Creativ-Ceutical, Hong Kong,
Hong Kong, 3Creativ-Ceutical K.K., Tokyo, Japan
PHP112 K8 LOCAL UTILITIES FOR LOCAL STUDIES: DATA AVAILABILITY AND METHODOLOGY IN JAPAN AND KOREA
Kim HR1, Chen X
1, Pyo J
2, Crawford B
3,1IMS Japan KK, Minato-ku, Tokyo, Japan,
2IMS Health Korea, Seoul, South Korea,
3IMS
Japan K.K., Minato-ku, Tokyo, Japan
PHP113 K9 REVIEW OF PRICING & INNOVATION IN KOREA & TAIWAN
Gambari J, Duttagupta S, Chowdhury CA,CBPartners, New York, NY, USA
PHP114 K10 A BARRIERS TO AND FACILITATORS OF THE USE OF HTA REPORTS BY POLICYMAKERS IN KAZAKHSTAN
Kostyuk A1, Akanov A
2, Nurgozhin T
3,1KazAHTA, Astana, Kazakhstan,
2Astana Medical University, Astana,
Kazakhstan, 3Nazarbayev University, National Laboratory Astana, Astana, Kazakhstan
PHP115 L1 TRENDS IN HEALTH TECHNOLOGY ASSESSMENTS SINCE THE INTRODUCTION OF COST-EFFECTIVENESS IN THE NETHERLANDS
Dvortsin E, Vondeling G, van der Woude T, Postma MJ,University of Groningen, Groningen, The Netherlands
HEALTH CARE USE & POLICY STUDIES - Population Health
PHP116 L2 SCIENTIFIC EPIDEMIOLOGY AND HEALTH ECONOMICS: A RETROSPECTIVE ANALYSIS ON PESTICIDE CONSUMPTION AND SURVIVORS IN TELANGANA STATE-INDIA
Banoth SL,Kakatiya University, Warangal, India
PHP117 L3 ESTIMATING THE CONTRIBUTION ON THE REDUCTION OF THE BURDEN OF IRON DEFICIENCY ANEMIA FROM THE CURRENT FORTIFICATION STRATEGY OF COMMERCIAL FOODS TARGETED TO INFANTS AND TODDLERS IN INDIA. SCENARIOS USING SYSTEMATIC REVIEW AND REAL WORLD EVIDENCE
Detzel P,Nestle Research Center, Lausanne, Switzerland
HEALTH CARE USE & POLICY STUDIES - Prescribing Behavior & Treatment Guidelines
PHP118 L4 HOW GIFTS AND BRAND REMINDERS INFLUENCE THE GENERIC BRAND SELECTION AMONG PHYSICIANS?
Muragundi PM, Bharath K, Udupa N,Manipal University, Manipal, India
PHP119 L5 EVALUATION OF SOCIAL SECURITY ORGANIZATION'(SSO) REGULATIONS ON PHYSICIAN PRESCRIBING PATTERN IN IRAN IN 2014
Soleymani F1, Kebriaeezadeh A
2,1Tehran University of Medical Sciences, Tehran, Iran (Islamic Republic of),
2Tehran University
of Medical Sciences, Faculty of Pharmacy, Tehran, Iran (Islamic Republic of)
PHP120 L6 USE OF CLINICAL INTELLIGENCE IN MONITORING RATIONAL DRUG USE INDICATORS IN THAILAND
Phraewphiphat R, Piebpien P, Bunupuradah P, Pattanaprateep O, Leelaudomlipi S,Faculty of Medicine Ramathibodi Hospital,
Mahidol University, Bangkok, Thailand
PHP121 L7 PROSPECTIVE STUDY OF THE INCIDENCE, NATURE AND CAUSES OF DISPENSING ERRORS IN COMMUNITY PHARMACIES OF ULAANBAATAR, MONGOLIA
Gendenragchaa B, Dorj G, Dorj G, Sanjjav T,Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
HEALTH CARE USE & POLICY STUDIES - Quality of Care
PHP122 L8 THE ACCURACY OF PATIENT SELF REPORT IN MEASURING CONTINUITY OF CARE IN AUSTRALIA
Wright M,University Technology Sydney, Broadway, Australia
PHP123 L9 MEDICATION RECONCILIATION: A TOOL FOR BETTER PATIENT CARE
Vangaveti T1, Karimkuttickal NM
1, P SK
1, P SK
1, Vilakkathala R
2, Mallayasamy S
2, Stanley W
2,1Manipal College of
Pharmaceutical Sciences, Manipal, India, 2Manipal University, Manipal, India
HEALTH CARE USE & POLICY STUDIES - Regulation of Health Care Sector
PHP124 L10 INTERNATIONAL REFERENCE PRICING'S EVOLUTION IN CHINA
Guan Y,Sanofi China, Shanghai, China
PHP125 M1 A COMPARISON OF NATIONAL GUIDELINES FOR NETWORK META ANALYSIS
Laws AJ,Icon Plc, Vancouver, BC, Canada
HEALTH CARE USE & POLICY STUDIES - Risk Sharing/Performance-Based Agreements
PHP126 M2 PRICING AND MARKET ACCESS OF ORPHAN DRUGS IN CHINA: ANALYSIS OF NATIONAL AND PROVINCIAL POLICY AND THE ASSOCIATED IMPACT ON COVERAGE
Sherwin G, Akpinar P, Yap B,ICON plc, LONDON, UK
PHP127 M3 DEVELOPMENT OF HTA IN KAZAKHSTAN
Bektur C,Nazarbayev University, National Laboratory Astana, Astana, Kazakhstan
PHP128 M4 ADOPTION OF MANAGED ENTRY AGREEMENTS IN ESTABLISHED AND EMERGING MARKETS
Xue Y1, Montilva J
2, Degun R
1,1Navigant Consulting Inc, London, UK,
2Navigant Consulting, London, UK
PHP129 M5 ANALYSIS ON THE REGIONAL DISTRIBUTION OF TELEMEDICINE IN CHINA
Lu B,Shenyang Pharmaceutical University, shenyang,China, China
HEALTH CARE USE & POLICY STUDIES - Conceptual Papers
PHP130 M6 A CONCEPTUAL FRAMEWORK FOR TACKLING MARKET ACCESS CHALLENGES IN ASIA
Umareddy I,Kantar Health, Singapore, Singapore
PHP131 M7 UNDERSTANDING CONTINUITY OF CARE AT A PROVIDER AND PRACTICE LEVEL
Wright M,University Technology Sydney, Broadway, Australia
PHP132 M8 NEED OF COSMETOVIGILANCE IN INDIA
Udupa N, Ligade V,Manipal University, Manipal, India
PHP133 M9 USE OF HEALTH ECONOMIC INFORMATION IN THE MANAGEMENT OF HEALTH CARE RESOURCE ALLOCATION
Maharajan M1, Rajiah K
2, Sivanandy P
2,1International Medical University Malaysia, Kuala Lumpur, Malaysia,
2International
Medical University, Kuala Lumpur, Malaysia
PHP134 M10 DO NUTRITION INTERVENTIONS REQUIRE A DIFFERENT APPROACH TO ECONOMIC EVALUATION?
Drummond M1, Fattore G
2,1University of York, Heslington, York, UK,
2SDA-Bocconi School of Management, Centre for
Research in Healthcare Management (CERGAS), Milano, Italy
PHP135 N1 A CONCEPTUAL FRAMEWORK OF BASELINE EQUITY FOR RURAL BASIC MEDICAL INSURANCE IN CHINA: BASED ON POLICY PROCESS THEORY
Wu J, Liu J, Zhu B, Mao Y,Xi'an Jiaotong University, Xi'an, China
PHP136 N2 PRACTICE BASED OUTCOME RESEARCH IN COMMUNITY PHARMACY
Rajiah K, Maharajan M, Sivanandy P,International Medical University, Kuala Lumpur, Malaysia
DISEASE- SPECIFIC STUDIES
GASTROINTESTINAL DISORDERS - Clinical Outcomes Studies
PGI1 N3 A SYSTEMATIC REVIEW AND META-ANALYSIS ON TOLERABILITY AND EFFICACY OF SOFOSBUVIR CONTAINING REGIMENS IN HEPATITIS C PATIENTS WITH STAGE 4-5 CHRONIC KIDNEY DISEASE
Singhal R, Ahlawat R, Tiwari P,National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali),
Punjab, India
PGI2 N4 META-ANALYSIS OF THE EFFECTIVENESS ON PEGINTERFERON FOR CHRONIC HEPATITIS C
Chen PY1, Ma AX
2,1China pharmaceutical university, Nanjing, China,
2China Pharmaceutical University, Nanjing, China
GASTROINTESTINAL DISORDERS - Cost Studies
PGI3 N5 HOSPITAL ADMISSIONS AND COSTS OF CROHN'S DISEASE IN NEW ZEALAND AND THE IMPACT OF ADALIMUMAB
Milne RJ1, Gearry RB
2, Eglinton TW
2,1University of Auckland, Auckland, New Zealand,
2University of Otago at Christchurch,
Christchurch, New Zealand
PGI5 N7 TREATMENT COST ESTIMATION OF CHRONIC GASTRITIS CAUSED BY HELICOBACTER PYLORI
Odsuren M1, Sarantuya T
2, Undram L
3,1First Central Hospital of Mongolia, Ulaanbaatar, Mongolia,
2United Family Intermed
Hospital, Ulaanbaatar, Mongolia, 3Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
PGI6 N8 A COST-UTILITY ANALYSIS OF DIFFERENT ANTIVIRAL MEDICINE REGIMENS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1 in Iran
Alavian SM1, Nikfar S
2, Kebriaeezadeh A
2, Rezaei Hemami M
3, Sanati E
2, Keshavarz K
4,1Baqiyatallah Research Center for
Gastroenterology and Liver Diseases, Tehran, Iran (Islamic Republic of), 2Tehran University of Medical Sciences, Faculty of
Pharmacy, Tehran, Iran (Islamic Republic of), 3University of Glasgow, Glasgow, UK,
4Shiraz University of Medical Sciences, School
of Management and Information Sciences, Shiraz, Iran (Islamic Republic of)
GASTROINTESTINAL DISORDERS - Patient-Reported Outcomes & Patient Preference Studies
PGI7 N9 ESTIMATING UTILITIES FOR LIVER DISEASES USING STANDARD GAMBLE METHOD
Jo M, Ock M, Lim SY,University of Ulsan College of Medicine, Seoul, South Korea
PGI8 N10 A STUDY ON DRUG UTILIZATION AND DRUG RELATED PROPLEMS AMONG ANTI-ULCER PATIEND ADMITTED IN TEACHING HOSPITAL
Ramkanth S1, Thattakudian Sheikuduman MS
2, Thiruvengadarajan V
1, Chakka G
2,1Annamacharya College of Pharmacy, Kadapa,
India, 2Annamacharya College of Pharmacy, YSR Kadapa, India
PGI9 O1 ESTIMATION OF WILLINGNESS TO PAY FOR A QUALITY-ADJUSTED LIFE YEAR ON A CURE
Song HJ1, Lee E
2,1SungKyunKwan University, Suwon, South Korea,
2Sungkyunkwan University, Suwon, South Korea
GASTROINTESTINAL DISORDERS - Health Care Use & Policy Studies
PGI10 O2 THE FOLLOW-UP AND UTILIZATION OF DRUG TREATMENT FOR CHRONIC HBV/HCV PATIENTS WITH MAJOR PSYCHIATRIC DISEASES IN TAIWAN
Tsai C, Chang C, Tang C, Lin Y, Lu S,Taipei Medical University, Taipei, Taiwan
PGI11 O3 REAL LIFE DRUG UTILIZATION AND BIOLOGICS EFFECTIVENESS IN PATIENTS WITH CROHN'S DISEASE – A POPULATION-BASED STUDY IN TAIWAN
Smulders M1, Cheng C
2, Lien HP
3, Liang H
4, Khalid JM
5, Kao Yang Y
2,1SmartAnalyst, New York, NY, USA,
2National Cheng Kung
University, Tainan, Taiwan, 3Takeda Pharmaceuticals Taiwan, Ltd., Taipei, Taiwan,
4Takeda Development Center Americas, Inc,
Deerfield, IL, USA, 5Takeda Development Centre Europe Ltd, London, UK
PGI12 O4 POLICY EVALUATION ON“THE PAY-FOR-PERFORMANCE PROGRAM OF HEPATITIS B AND C” IN TAIWAN
Lu S, Tang C, Lin Y, Tsai C,Taipei Medical University, Taipei, Taiwan
PGI13 O5 THE ROLE OF INSULIN-LIKE GROWTH FACTOR-1 ON STEATOHEPATITIS
Bulur O, Dal K, Ertugrul dT, Aydoğan Y, Beyan E, Karadag I, Ünsal O,keçiören research hospital ANKARA /TURKEY, Ankara,
Turkey
PGI14 O6 HEART RATE RECOVERY IN İNFLAMMATORY BOWEL DISEASE (IBD)
Ünsal O, Karakaya S, Bulur O, Dal K, Uzman M, Eser M, Aydogan Y,keçiören research hospital ANKARA /TURKEY, Ankara,
Turkey
PGI15 O7 KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS HEPATITIS B AMONG MEDICAL COLLEGE STUDENTS OF QUETTA, PAKISTAN
ul Haq N1, Malik Z
1, Nasim A
1, Riaz S
1, Mohammad G
1, Azhar S
2,1University of Balochistan, Quetta, Pakistan,
2Comsats Institute
of Information Technology, Abbottabad, Pakistan
MENTAL HEALTH - Clinical Outcomes Studies
PMH1 O8 CLINICAL OUTCOMES OF BIPOLAR DISORDER ON LONG-TERM TREATMENT WITH LITHIUM WITH OR WITHOUT MOOD STABILIZERS
De Guzman GQ,Virgen Milagrosa University Foundation, San Carlos City, Pangasinan, Philippines
PMH2 O9 PREVALENCE AND CHARACTERISTICS OF MENTAL DISORDERS AMONG HOSPITALIZED BREAST CANCER PATIENTS IN THE UNITED STATES
Wang X, Xiao H,University of Florida, Gainesville, FL, USA
PMH3 O10 CROSS-VALIDATION OF A 7-ITEM CLINICAL DECISION RULE FOR DETECTING PANIC-RELATED ANXIETY IN EMERGENCY MEDICINE PATIENTS
Sung SC1, Rush AJ
1, Earnest A
2, Lim LE
3, Lim SH
3, Ong ME
3,1Duke-NUS Medical School, Singapore, Singapore,
2Monash
University, Melbourne, Australia, 3Singapore General Hospital, Singapore, Singapore
PMH4 P1 SOMATIC SYMPTOMS IN PATIENTS WITH UNDIAGNOSED DEPRESSION: PREVALENCE AND HEALTH CARE UTILIZATION IN JAPAN
Takahashi O, Ohde S,St.Luke's International University, Tokyo, Japan
PMH5 P2 CLINICAL EFFECTIVENESS TELEPSYCHOTHERAPY FOR DEPRESSION DISORDER: A SYSTEMATIC REVIEW
Park JJ1, Kim S
2, Park D
2,1National Evidence-based Collaborating Agency, Seoul, South Korea,
2National Evidence-based
Healthcare Collaborating Agency, Seoul, South Korea
PMH6 P3 COMPARATIVE EVALUATION OF SAFETY, EFFICACY AND COGNITIVE PROFILE OF AMISULPRIDE AND OLANZAPINE IN SCHIZOPHRENIA PATIENTS- A PROSPECTIVE STUDY
Ramesh S, Sivakumar P, Prashant C, Sivasankar M, Manikandhan C, Jai Ganesh KP,Nehru College of Pharmacy, Thrissur
District, India
PMH7 P4 PREVALENCE OF ANTICHOLINERGIC DRUG USE IN OLDER ADULTS WITH DEMENTIA
Ong YS, Fong TY, Chen LL, Chiang YY, Lim KW, Koh L, Mamun K,Singapore General Hospital, Singapore, Singapore
MENTAL HEALTH - Cost Studies
PMH8 P5 ESTIMATING THE ECONOMIC BURDEN OF TREATMENT RESISTANT DEPRESSION IN TAIWAN USING THE NHIRD
Klug J1, Yu F
2, Chang C
3, Juang H
4, Wang M
5, Fife D
6, Liu C
4, Wang BC
7,1Janssen Asia Pacific, Kowloon, Hong Kong,
2Janssen
Asia Pacific, Beijing, China, 3Chang Gung University, TaoYuan, Taiwan,
4Chang Gung Memorial Hospital, Tao-Yun,
Taiwan, 5Janssen Taiwan, Taipei, Taiwan,
6Janssen, pharmaceutical company of Johnson and Johnson, Titusville, NJ,
USA, 7Elysia Group Ltd, Taipei, Taiwan
PMH9 P6 ECONOMIC BURDEN OF SCHIZOPHRENIA IN CHINA: A LITERATURE REVIEW
Jia Y1, Cheng X
2, Aballea S
3, Dorey J
3, Toumi M
4,1Shenyang Pharmaceutical University, Shenyang, China,
2Creativ-Ceutical,
Hong Kong, Hong Kong, 3Creativ-Ceutical, Paris, France,
4Aix-Marseille University, Marseille, France
PMH10 P7 THE ECONOMIC BURDEN OF SCHIZOPHRENIA IN MALAYSIA
Teoh SL1, Chaiyakunapruk N
1, Chong HY
1, Aziz SA
2, Chemi N
2, Othman AR
2, Zaki NM
2, Vanichkulpitak P
3,1Monash University
Malaysia, Selangor, Malaysia, 2Hospital Kuala Lumpur, Kuala Lumpur, Malaysia,
3Silpakorn University, Nakhon Pathom, Thailand
PMH11 P8 ESTIMATED RANGE OF COST OF TREATMENT OF ADULT SCHIZOPHRENIA PATIENTS AT A TERTIARY HOSPITAL AS OF OCTOBER 2015
Abala AT, Bautista T,University of the Philippines-Philippine General Hospital, Manila, Philippines
PMH12 P9 A COST-EFFECTIVENESS ANALYSIS OF GUANFACINE EXTENDED-RELEASE TREATMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Maeda S, Shimozuma K, Takeda Y,Ritsumeikan University, Kusatsu, Japan
PMH13 P10 AN ECONOMIC MODEL OF ADVANCE CARE PLANNING: A COST EFFECTIVE INTERVENTION FOR PEOPLE WITH DEMENTIA
Nguyen K,Griffith University, Brisbane, Australia
PMH14 Q1 COST-UTILITY ANALYSIS EVALUATING VORTIOXETINE VERSUS VENLAFAXINE XR AND AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN TAIWAN
Brignone M1, Atsou K
1, Reynaud-Mougin C
2, Chen W
3, Milea D
4,1Lundbeck SAS, Paris, France,
2H. Lundbeck A/S, Copenhagen,
Denmark, 3Hoan Pharmaceuticals Ltd., Taipei, Taiwan,
4Lundbeck Singapore Pte Ltd, Singapore, Singapore
PMH15 Q2 REAL-WORLD HEALTH OUTCOMES, ECONOMIC IMPACTS, AND COST-EFFECTIVEENESS OF A BEIJING MUNICIPAL GOVERNMENT FUNDED FREE-DRUG RPOGRAM IN COMMUNITY SCHIZOPHRENIA PATIENTS IN BEIJING, CHINA
Yan F1, Yang Y
2, Jia P
3, Huang Q
1, Chen Y
1, Du F
3, Yang Y
3, Chen W
3,1Beijing Anding Hospital of Capital Medical University,
Beijing, China, 2Beijing Municipal Commission of Health and Family Planning, Beijing, China,
3Beijing Community Services
Association, Beijing, China
PMH16 Q3 ESTIMATING THE ECONOMIC IMPACT DUE TO PRODUCTIVITY LOSSES OF DIABETES AND MAJOR DEPRESSIVE DISORDER IN SINGAPORE: HUMAN CAPITAL VERSUS FRICTION COST APPROACHES
Brooks-Rooney C1, Griffiths M
2, Chen G
1,1Costello Medical Singapore Pte Ltd, Singapore, Singapore,
2Costello Medical
Consulting Ltd, Cambridge, UK
MENTAL HEALTH - Patient-Reported Outcomes & Patient Preference Studies
PMH17 Q4 ASSESS THE MEDICATION ADHERENCE IN PATIENTS WITH SEVERE MENTAL ILLNESS ATTENDING PUBLIC TERTIARY CARE HOSPITALS OF QUETTA, PAKISTAN
ul Haq N1, Ahmed N
1, Rasool G
2, Illyas M
2, Nasim A
1,1University of Balochistan, Quetta, Pakistan,
2Baluchistan Institute of
Psychiatry and Behavioral Sciences, Quetta, Pakistan
PMH18 Q5 THE MEDICATION ADHERENCE IN SCHIZOPHRENIA MANAGEMENT BY USING SECOND GENERATION ANTIPSYCHOTICS IN TAIWAN: A POPULATION STUDY BASED ON NHRID
Chung C1, Tai TA
2, Chou KP
2,1Mackay Medical College, New Taipei City, Taiwan,
2IMS Health Taiwan, Taipei, Taiwan
PMH19 Q6 QUALITY OF LIFE MEASURED WITH EQ-5D IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN JAPAN
Sakurai K1, Yoshimura K
2, Arima H
3,1The University of Tokyo, Tokyo, Japan,
2Chiba University, Chiba, Japan,
3Shinagawa
Ekimae Mental Clinic, Tokyo, Japan
PMH22 Q7 ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS WITH SEVERE MENTAL ILLNESS ATTENDING TERTIARY CARE PUBLIC HOSPITALS OF QUETTA, PAKISTAN
ul Haq N1, Ahmed N
1, Rasool G
2, Illyas M
2, Nasim A
1,1University of Balochistan, Quetta, Pakistan,
2Baluchistan Institute of
Psychiatry and Behavioral Sciences, Quetta, Pakistan
MENTAL HEALTH - Health Care Use & Policy Studies
PMH23 Q8 IS THERE A DIFFERENCE IN PERCEPTION AND PRACTICE IN PHARMACOLOGICAL MANAGEMENT OF SCHIZOPHRENIA- A CROSS SECTIONAL SURVEY IN INDIA
Gundugurti PR1, Nagpal R
2, Sheth AS
3, Narang P
4, Gawande SJ
4, Sharma S
4, Klug J
5,1Asha Hospital, Hyderabad,
India, 2Manobal Klinik, New Delhi, India,
3Unlimited Potentialities, Mumbai, India,
4Johnson & Johnson India Private Limited,
Mumbai, India, 5Johnson & Johnson Hongkong, Kowloon, Hong Kong
PMH24 Q9 ASIANS' MENTAL HEALTH STATUS IN A U.S. MIDWESTERN METROPOLIS, 2004 -2013
Liu Y1, Cai J
2, Okah FA
3,1University of Missouri–Kansas City, Kansas City, MO, USA,
2Kansas City Health Department, Kansas
City, MO, USA, 3University of Missouri - Kansas City, Kansas City, MO, USA
PMH25 Q10 TREATMENT RESISTANT DEPRESSION DEVELOPMENT FROM MAJOR DEPRESSIVE DISORDER: A CLAIMS DATABASE ANALYSIS IN JAPAN
Tsukazawa SK1, Fife D
2, Shimamoto K
3, Mahlich J
1,1Janssen Pharmaceuticals KK, Tokyo, Japan,
2Janssen, pharmaceutical
company of Johnson and Johnson, Titusville, NJ, USA, 3MediStatLab, Tokyo, Japan
PMH26 R1 EXERCISE AND FACTORS INFLUENCE MENTAL HEALTH OF UNDERGRADUATED STUDENTS AT BURAPHA UNIVERSITY IN 2014
Phanudulkitti C, Nawkij P, Sungkaeo A, Thanmarak P, Auamnoy T,Burapha University, Chonburi, Thailand
SENSORY SYSTEMS DISORDERS - Clinical Outcomes Studies
PSS1 R2 LONG-TERM FOLLOW-UP OF RANIBIZUMAB TREATED PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM THE RADIANCE CLINICAL TRIAL IN FOUR EAST ASIAN COUNTRIES
Skelly A1, Lara N
2, Pedros M
2, Macfadden W
3,1Novartis Ireland Limited, Dublin, Ireland,
2IMS Health, Barcelona, Spain,
3Novartis
Pharma AG, Basel, Switzerland
SENSORY SYSTEMS DISORDERS - Cost Studies
PSS2 R3 SENSITIVITY ANALYSIS OF ANTIBIOTIC COST IN CHRONIC SUPPURATIVE OTITIS MEDIA PATIENTS IN SOUTH INDIA: A RETROSPECTIVE OBSERVATIONAL STUDY
Kumar S1, Jayachandran L
1, Kumar A
1, A S
1, R B
2,1Manipal University, Manipal, India,
2Manipal university, Manipal, India
PSS3 R4 ANALYSIS OF TWO PRESSURE ULCER DRESSINGS FOR COST REDUCTION IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Tolentino AC1, Dick S
2, Amaya R
3,1Hospital Universitario Pedro Ernesto - UERJ/HUPE, Rio de Janeiro, Brazil,
2The College Of
St. Scholastica, Duluth, MN, USA, 3Pediatric Wound Care & Laser Specialists, Houston, TX, USA
PSS4 R5 APPLICATION OF VALUE OF INFORMATION ANALYSIS TO MINIMIZE DECISION RISK IN MALAYSIA
Chong HY1, Wu BC
2, Chaiyakunapruk N
1,1Monash University Malaysia, Selangor, Malaysia,
2Ministry of Health Singapore,
Singapore, Singapore
SENSORY SYSTEMS DISORDERS - Patient-Reported Outcomes & Patient Preference Studies
PSS5 R6 BARRIERS TO INTRAVITREAL INJECTION THERAPY ADHERENCE IN DME PATIENTS IN AUSTRALIA
Schnabel R1, Tan J
2, Cullip T
3, Guinan G
3, Cameron C
1,1Allergan Australia Pty Ltd, Gordon, Australia,
2Allergan Pte Ltd,
Singapore, Singapore, 3So What Research Pty Ltd, Potts Point, Australia
PSS6 R7 ASSESSING THE OUTCOMES OF PROSTHETIC TREATMENT IN LOWER OVERDENTURE WEARERS
Kordiyak A, Bratus-Hrynkiv R,Danylo Halytskyi Lviv National Medical University, Lviv, Ukraine
PSS7 R8 PREDICTED DEMAND FOR A NEW INJECTABLE SOLUTION FOR DELIVERING GLAUCOMA MEDICINE
Ozdemir S1, Wong T
2, Finkelstein EA
3,1Duke-NUS Medical School, Singapore, Singapore,
2Singapore National Eye Centre,
Singapore, Singapore, 3Duke NUS Medical School, Singapore, Singapore
PSS8 R9 Fabrication and Characterization of Anti-Vitiligo Cream containing 5% Hydroalchohlic Extract of Psoralia Corylifolia.
Hussain I1, Hussain N
2, Manan A
1, Ali B
3, Rashid A
4,1SMBB Medical University, Larkana, Larkana, Pakistan,
2BZU, Multan,
Multan, Pakistan, 3Gomal University, Dera Ismail Khan, Pakistan,
4DRAP Pakistan, Islamabad, Pakistan
PSS9 R10 THE EFFECT OF TRADITIONAL MEDICINE ON QUALITY OF LIFE IN PATIENTS WITH ATOPIC DERMATITIS: A REVIEW OF RECENT CLINICAL TRIALS
Ko Y, Cheon C, Jang B, Ko S,Kyung Hee University, Seoul, South Korea
SENSORY SYSTEMS DISORDERS - Health Care Use & Policy Studies
PSS10 S1 DRUG UTILIZATION EVALUATION OF AMOXICILLIN-CLAVULANIC ACID IN CSOM PATIENTS IN A SOUTH INDIAN HOSPITAL: A RETROSPECTIVE ANALYSIS
Jayachandran L1, Kumar A
1, Kumar S
1, R B
2, A S
1,1Manipal University, Manipal, India,
2Manipal University, Udupi, India
PSS11 S2 ANTIMICROBIAL SUSCEPTIBILITY PATTERN IN CHRONIC SUPPURATIVE OTITIS MEDIA PATIENT IN A TERTIARY CARE HOSPITAL
Kumar A1, Jayachandran L
1, Kumar S
2, R B
3, A S
2,1Manipal university, Manipal,udipi, India,
2Manipal University, Manipal,
India, 3Manipal university, Manipal, India
URINARY/KIDNEY DISORDERS - Clinical Outcomes Studies
PUK1 S3 BURDEN OF CHILDHOOD ONSET CHRONIC KIDNEY DISEASE
Hsu C1, Tain Y
2,1Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan,
2Kaohsiung Chnag Gung Memorial Hospital,
Kaohsiung, Taiwan
PUK2 S4 CLINICAL EFFECTIVENESS OF CARBAPENEM VERSUS ALTERNATIVE ANTIBIOTICS FOR URINARY TRACT INFECTION DUE TO ENTEROBACTERIACEAE PRODUCING ESBL: A SYSTMATIC REVIEW
Park JJ1, Rhee J
2, Park D
2,1National Evidence-based Collaborating Agency, Seoul, South Korea,
2National Evidence-based
Healthcare Collaborating Agency, Seoul, South Korea
PUK3 S5 ETIOLOGY AND OUTCOME OF ACUTE KIDNEY INJURY IN SOUTH INDIAN POPULATION
Zabiuddin Ahad M1, Suresh AA
1, Kumar P
1, Attur RP
2,1Manipal College of Pharmaceutical Sciences, Manipal, India,
2Department
of Nephrology, Kasturba Medical College, Manipal University, Manipal, India
URINARY/KIDNEY DISORDERS - Cost Studies
PUK4 S6 ESTIMATING THE COST OF END-STAGE RENAL DISEASE TO THE HOSPITAL SYSTEM IN SINGAPORE
Sidharta SD1, Yang F
2, Yoong JS
1,1National University of Singapore, Singapore, Singapore,
2University of Manchester,
Manchester, UK
PUK5 S7 COMPARATIVE ANALYSIS ON THE OUT-OF-POCKET EXPENDITURE AMONG PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE BETWEEN MEDICAL INSURANCE COVERED AND UNCOVERED AREAS IN CHINA
Wu J, Liu J, Zhu B, Mao Y,Xi'an Jiaotong University, Xi'an, China
PUK6 S8 PHARMACOECONOMIC EVALUATION OF PATIENTS UNDERGOING HEMODIALYSIS AT A TERTIARY CARE CENTRE
Prasad S, Kaza S, Prasad N S, Prabhu RA, Rangaswamy D, Shenoy S, Saraf K,Kasturba Medical College Manipal, Manipal
University, Manipal, Udupi, Karnataka, India
PUK7 S9 COST-EFFECTIVENESS OF A COMBINATION OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS (RAS)/CALCIUM CHANNEL BLOCKERS (CCB) OR RAS MONOTHERAPY TO RETARD PROGRESSION OF KIDNEY DISEASE IN MALAYSIA
Mohd Tahir NA1, Thomas P
2, Makmor Bakry M
3, Abdul Gafor AH
4, Li SC
1,1University of Newcastle, Callaghan, NSW,
Australia, 2Taylor's University, Selangor, Malaysia,
3Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia,
4Universiti
Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
PUK8 S10 COST EFFECTIVENESS OF OVERACTIVE BLADDER TREATMENT WITH MIRABEGRON IN PATIENTS IN SOUTH KOREA
Suh D1, Lee S
1, Lim SJ
1, Song J
1, Ko G
2,1Chung-Ang University, Seoul, South Korea,
2Astellas Pharma Inc., Seoul, South Korea
URINARY/KIDNEY DISORDERS - Patient-Reported Outcomes & Patient Preference Studies
PUK10 T1 PATIENT ENGAGEMENT: TO SUPPORT MEDICATION ADHERENCE IN KIDNEY TRANSPLANTATION
Low JK1, Crawford K
1, Manias E
2, Williams A
1,1Monash University, Clayton, Australia,
2Deakin University, Burwood, Australia
PUK11 T2 LONGITUDINAL TRAJECTORIES OF DEPRESSIVE AND ANXIOUS SYMPTOMS FOLLOWING A SELF-MANAGEMENT INTERVENTION FOR HAEMODIALYSIS PATIENTS
Lam KF1, Mooppil N
2, Ng HJ
1, Kang AW
1, McBain H
3, Newman S
3, Griva K
1,1Department of Psychology, Faculty of Arts and
Social Sciences, National University of Singapore, Singapore, Singapore, 2National Kidney Foundation, Singapore, Singapore,
Singapore, 3School of Health Sciences, City University London, London, UK
PUK12 T3 PROGRESSION AND OUTCOMES OF NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS
Khan YH1, Sarriff A
1, Adnan AS
2, Khan AH
1, Mallhi TH
3,1Universiti Sains Malaysia, Pulau Pinang, Malaysia,
2University Sains
Malaysia, Kota Bharu, Malaysia, 3University Sains Malaysia, Pulau Penang, Malaysia
PUK13 T4 QUALITY OF LIFE FOR PATIENTS USING HEMODIALYSIS (HD) VS. PERITONEAL DIALYSIS (PD) MODALITIES IN TAIWAN
Kuo C, Hsieh W, Tang C,Taipei Medical University, Taipei, Taiwan
URINARY/KIDNEY DISORDERS - Health Care Use & Policy Studies
PUK14 T5 CLINICAL PROFILE AND MANAGEMENT OF CHRONIC KIDNEY DISEASE IN INDIAN GERIATRIC PATIENTS AT A PUBLIC TERTIARY CARE HOSPITAL: A CROSS-SECTIONAL STUDY
Tiwari P1, Ahlawat R
1, D'Cruz S
2,1National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali),
Punjab, India, 2Government Medical College & Hospital, Chandigarh, India
PUK15 T6 MANAGEMENT AND OUTCOMES OF ACUTE KIDNEY INJURY
Kumar P1, Suresh AA
1, Ahad MZ
1, Attur RP
2,1Manipal College Of Pharmaceutical Sciences, Manipal, India,
2Department of
Nephrology, Kasturba Medical College, Manipal University, Manipal, India
PUK16 T7 STOCK REDUCTION OF ERYTHROPOIETIN FOR PATIENTS ON HEMODIALYSIS AT SOMDECH PHRA DEBARATANA MEDICAL CENTER
Inmuanghiranchot S, Supapsophon P, Aim-oat A, Lohvithee P, Chandraruangnabha Y, Piluk W,Ramathibodi hospital, Bangkok,
Thailand